Upregulation of p300 in Paclitaxel-Resistant TNBC: Implications for Cell Proliferation via the PCK1/AMPK Axis

The authors explored the role of p300 in the context of paclitaxel resistance in TNBC cells, focusing on its interaction with the phosphoenolpyruvate carboxykinase 1 (PCK1)/adenosine monophosphate-activated protein kinase (AMPK) pathway.